Previous Article in Journal
Individual- and Community-Level Predictors of Birth Preparedness and Complication Readiness: Multilevel Evidence from Southern Ethiopia
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Epidemiologia
Volume 7
Issue 1
10.3390/epidemiologia7010014
epidemiologia-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Trends and Determinants of Dementia-Related Mortality in Mexico, 2017–2023

by
Dennis M. Lopez-Samayoa
1,†,
Angel M. Campos-Sosa
2,
Paola Asuncion Bojorquez-Chan
3,
Sara E. Martinez-Medel
4,
Jorge C. Guillermo-Herrera
4,*,
Edgar Villarreal-Jimenez
3,4,
Reinhard Janssen-Aguilar
5,
Cristina Rodriguez Peres-Mitre
4,† and
Nina Mendez-Dominguez
4,*
1
School of Medicine, Universidad Autonoma de Durango, Durango 34200, Mexico
2
School of Medicine, Universidad Marista de Merida, Merida 97302, Mexico
3
Centro Educativo Rodríguez Tamayo, Cd. Caucel, Merida 97314, Mexico
4
Hospital Regional de Alta Especialidad de la Peninsula de Yucatan, Servicios de Salud del Instituto Mexicano del Seguro Social, IMSS-BIENESTAR, Merida 97130, Mexico
5
Interventional Psychiatry Program, St. Michael’s Hospital, Toronto, ON M5B 1W8, Canada
*
Authors to whom correspondence should be addressed.
†
These authors contributed equally as first authors.
Epidemiologia 2026, 7(1), 14; https://doi.org/10.3390/epidemiologia7010014
Submission received: 20 September 2025 / Revised: 2 November 2025 / Accepted: 15 December 2025 / Published: 20 January 2026
Browse Figures
Versions Notes

Abstract

Background: Dementia is an increasing public health challenge in Mexico, yet recent national data on mortality patterns remain limited. This study examines temporal trends in dementia-related mortality and its sociodemographic and ecological characteristics among adults aged ≥65 years from 2017 to 2023. Methods: National mortality records from the General Directorate of Health Information were analyzed. Annual dementia-related mortality rates were calculated based on mid-year population estimates from CONAPO. Trends were assessed with regression analysis, including population offsets, and individual- and state-level characteristics were evaluated. Results: Between 2017 and 2023, dementia-related deaths increased from 761 to 1425, corresponding to an observed rise from 7.9 to 14.6 deaths per 100,000 inhabitants aged ≥65 years. Period trend indicated an average annual expected increase of 18.6% in dementia related mortality. A transient decline occurred in 2020–2021, coinciding with the COVID-19 pandemic. At the individual level, higher education was associated with greater odds of dementia certification, whereas Indigenous ethnicity appeared protective, which may reflect patterns consistent with diagnostic and reporting disparities. Higher state-level life expectancy correlated with higher dementia mortality, while greater population aging was inversely associated. Conclusions: Dementia-related mortality in Mexico shows a sustained upward trend with regional heterogeneity and apparent inequities in diagnosis and reporting. Strengthening mortality surveillance, improving certification quality, and integrating dementia indicators into national non-communicable disease registries are essential to guide equitable policy responses.

1. Introduction

Life expectancy is shaped by health care access, social determinants, and population health behaviors. While greater health care resources often extend longevity, system efficiency, education, and income inequality help explain why countries with similar expenditures may differ substantially in life expectancy [1,2]. Beyond spending, social protection, lifestyle factors, and satisfaction of health care needs are stronger determinants of survival [3].
However, increases in life expectancy do not always translate into a healthier life. A widening gap between life expectancy and health-adjusted life expectancy (HALE) has been documented, with many individuals spending additional years in poor health or disability [3,4,5,6]. This divergence underscores that prolonging life does not necessarily ensure quality of life. International studies, including those from Japan and China, confirm persistent disparities in healthy life expectancy despite health care expansion, largely influenced by resource distribution, socioeconomic status, and socioeconomic contextual factors [5,6,7,8].
In Mexico, life expectancy has risen in recent decades, yet autonomy and quality of life among older adults have not improved proportionally. Between 26.9% and 30.9% of older adults report some degree of dependency, and cognitive impairment is now a critical public health concern, affecting an estimated 1.3 million people with projections of 3.5 million by 2050 [9,10]. Dependency in later life results from multiple factors, such as chronic non-communicable diseases, such as diabetes and hypertension, sensory deficits, dementia, falls, and psychosocial factors, such as depression. Functional dependency is strongly linked to cognitive decline, particularly among women, individuals aged ≥75 years, and those with low education or limited resources [11].
Social determinants exacerbate vulnerability. Limited health care access, low socioeconomic status, and weak social networks are associated with functional dependency, poor self-rated health, and depression [12]. Many older Mexicans continue working beyond retirement age due to insufficient pensions, while gaps in universal coverage and persistent poverty deepen inequities [13,14], while indigenous identity intersects with health disadvantage, reflecting systemic barriers to care [14].
Recent political changes have shifted Mexico’s health system from a well-known yet imperfect insurance model to a potentially more inclusive system that remains under implementation. The transition from the known to the unknown is the moment we are living in today, and while some economists estimate that 80% of the population lacks health coverage, others anticipate a preventable crisis in highly specialized medical care. As a collateral effect of these changes, the elderly become more vulnerable and in need of specialized care for dementia [15,16,17], particularly because the public health system in Mexico is fragmented into subsystem institutions with profound differences in per-person health care budget, and deepening health inequities. Social determinants of health may affect an individual’s lifelong susceptibility to access health care and to cause-specific mortality; therefore, it is important to analyze individual characteristics related to dementia-related mortality and to identify national and state-clustered health indicators to help shape comprehensive strategies to mitigate dementia-related epidemiologic trends.
Cognitive impairment includes progressive neurodegenerative disorders such as Alzheimer’s disease, vascular dementia, and Parkinson’s disease dementia. Although aging is a major risk factor, dementia is not a normal consequence of aging. According to the National Population Council (CONAPO), adults aged ≥65 years represent about 9% of Mexico’s population in 2025, projected to reach 25% by 2050 [18]. Prior analyses identified higher dementia-related mortality among women, the oldest-old, urban residents, those with higher education, and individuals without a partner [19]. Dementia-related mortality in Mexico has not been sufficiently explained, given the context of population aging and changing health insurance coverage. Ecological analysis has proved useful for dementia-related mortality trend description [20].

Study Aim and Hypotheses

This study aims to evaluate annual trends in dementia-related mortality in Mexico from 2017 to 2023, as well as the association of these trends with population aging, life expectancy, and health service affiliation at the state level. We hypothesized that (1) individual analysis may bring light to determinants for dementia-related mortality, (2) dementia-related mortality increased annually, with a possible dip during the COVID-19 pandemic years, (3) states with a greater aging population would also show higher dementia-related mortality, and (4) states may exhibit variability in health insurance coverage, which is relevant for dementia-related care.

2. Materials and Methods

2.1. Study Design

We conducted an ecological study integrating both individual and state-cluster analyses to examine dementia-related mortality in Mexico.
At the individual level, we analyzed national death certificate data to identify sociodemographic factors associated with dementia-related mortality. To identify the mortality cases in Mexico, records were obtained from the National Institute of Statistics and Geography (INEGI 2017–2023). We included all registries of deaths of individuals aged ≥65 with basic diagnosis coded as F00–F03X in ICD-10. Records of the foreign residence of the deceased were excluded.
Individual-level variables were age (as both, continuous and categorized by group: 65–79, 80–99, ≥100), gender (male, female), marital status (if living with a sentimental partner or not), basic education level (≥high school or <high school) economic activity (active vs. inactive), medical insurance (yes/no), area of residence (urban vs. rural), town size (<500,000 vs. ≥500,000 inhabitants), and Indigenous ethnicity (yes/no).
For state-clusters, we used state indicators as variables; we included indicators of aging, defined as the percentage of the population aged ≥65 years old, life expectancy at birth (in years), and percentage of population aged >65 with health insurance coverage, using data from INEGI and CONAPO open access databases. At the population level, each state of residence constituted a cluster, yielding 32 clusters.

2.2. Statistical Analysis

Descriptive statistics summarize individual characteristics; numerical variables are presented as means and standard deviations (SD), and for nominal variables, frequencies and percentages. For state-clusters, numerical variables are presented in medians and interquartile ranges (IQR; 25–75).
Standardized mortality rates per 100,000 inhabitants aged ≥65 years were estimated using the annual mid-year population projections for individuals ≥65 years, derived from the CONAPO. Trends were estimated using projected and observed mortality during pandemic years (2020–2021) using log-linear Poisson estimation (E[Deathst] = Pt × exp (β0 + β1 × Yeart).
For the individual analysis, a binary logistic regression was performed to identify the association between sociodemographic characteristics and the population size of the deceased’s place of residence (<500,000 vs. ≥500,000 inhabitants), expressed as Odds Ratios (ORs), 95% Confidence Intervals (CIs), and significance levels.
For the state-cluster analysis, given the nature of the data, accounting for a count, discontinuous numeric variable, non-parametric regression was developed to estimate associations.
All analyses were conducted using Stata® 14.0, with statistical significance set at p < 0.05; graphics were performed with Excel using add-ins.

2.3. Ethical Considerations

This study used publicly available, de-identified secondary data. Institutional approval was obtained from the Research Board of the Hospital Regional de Alta Especialidad de la Peninsula de Yucatan, with approval number 2024-033.

3. Results

  • Annual Trends in Dementia-Related Mortality (2017–2023)
A total of 8077 dementia-related deaths were registered among individuals aged ≥65 years between 2017 and 2023; annual deaths increased from 761 in 2017 to 1425 in 2023, with a transient decline in 2020 (1052 deaths), coinciding with the COVID-19 pandemic. Nationwide mortality rates per 100,000 inhabitants ≥65 showed a significant annual increase according to the expected (Poisson log-linear) trend by about 18–19% per year during 2017–2023. If the pre-pandemic pattern continued uninterrupted, by contrast, the observed year-over-year change averaged 11–12%, reflecting the transient slowdown around 2020–2022. Figure 1 shows observed and predicted mortality by year, illustrating an upward trend with a dip in 2020.
2.
Individual-Level Sociodemographic Associations
At the individual level, we found that 60.6% of all dementia-related deaths were reported in women. The mean age at death was 85.4 (SD 7.7) years, which rose gradually from 84.4 to 85.2 years (p < 0.001), suggesting gains in longevity even among those dying with dementia; their demographic and social attributes can be found in Table 1.
Education patterns also changed modestly over time, as the proportion of individuals with at least elementary schooling increased across the studied period. In contrast, individuals cohabitating with a spouse declined slightly, while economic inactivity became more common. Medical insurance affiliation exhibited a decreasing trend, and proportionally more dementia-related deaths occurred among those without medical insurance. The proportion of individuals identified as indigenous remained relatively low across all years. The percentage of individuals living in a town with a population of less than 500 thousand inhabitants was 58.6%.
Binary logistic regression (Table 2) was performed to associate between individuals who resided in larger cities and socioeconomic determinants, showing that individuals from larger cities exhibited increased odds for elementary education or higher (OR 1.91, p < 0.001) and for medical insurance affiliation (2.22, p < 0.001) when compared to individuals residing in smaller cities or rural areas.
Conversely, belonging to an Indigenous group was less common among individuals residing in larger cities (OR 0.17, p < 0.001), and being economically active (OR 0.62, p < 0.001) was less likely among individuals residing in larger cities.
3.
State-Clusters Analysis
Dementia-related mortality among adults aged 65 and over exhibited variability across the 32 state-clusters. Baja California and Nuevo Leon exhibited higher median rates in the studied period (Figure 1). Overall interstate variability can be found in Figure 2.
In Mexico, the median percentage of the population aging was 45.5 (IQR = 7.8); the median life expectancy was 75.2 (IQR = 2.1); and the median Medical Insurance coverage was 14.2 (IQR = 14.4). To determine state-cluster-level indicators pertaining to dementia-related mortality, we used a non-parametric regression with the percentage of the population aging, life expectancy, and the percentage of the population with health insurance as independent variables. In the multivariate regression model (Table 3), life expectancy emerged as a robust predictor, with each additional year associated with a 2.49-point increase in dementia mortality (p = 0.003). Population aging showed an inverse association (Coefficient = −0.21, p = 0.016), suggesting that states with proportionally larger older populations do not necessarily experience higher dementia mortality rates. This finding may reflect differences in diagnostic practices, reporting, or competing mortality risks.
A higher life expectancy was significantly associated with increased dementia-related mortality, whereas population aging showed a modest but significant negative association. Medical insurance coverage was not significantly associated with mortality variation across states.

4. Discussion

The present study analyzed national trends in dementia-related mortality in Mexico from 2017 to 2023, combining individual-level sociodemographic information with ecological indicators at the state level. The findings demonstrate a steady annual increase in dementia mortality, with a temporary decline in 2020 coinciding with the COVID-19 pandemic. Sociodemographic disparities were observed at both levels of analysis, including paradoxical associations that likely reflect differences in diagnosis, reporting, and survival patterns.
Our results from the present study showed an annual increase in dementia-related mortality among adults ≥ 65 years, even after adjusting for the pandemic years. This aligns with international reports of rising dementia burden, driven by population aging and increased recognition of cognitive impairment [1,21,22]. The observed decline in 2020 is consistent with pandemic-related disruptions: dementia may have been under-recorded on death certificates as COVID-19 dominated clinical care and vital statistics [23,24]. Similar patterns of underestimation during the pandemic have been reported in the United States, Spain, and Latin America [25,26].
At the individual level, dementia-related mortality occurred predominantly in women and in the oldest-old, consistent with global evidence of sex differences in dementia incidence and survival [27,28,29]. The gradual increase in age at death suggests improvements in overall survival, echoing trends documented in high-income countries [30].
Certain findings from the present study appear paradoxical. For example, a higher educational attainment was associated with greater odds for dementia-related mortality in larger cities, and despite education being a well-established protective factor against cognitive decline [31], it is also considered that more educated cohorts live longer, increasing their likelihood of dying later, when dementia mortality becomes more frequent. It may also indicate greater diagnostic accuracy in more educated individuals, as physicians may more readily evidence and record dementia on death certificates.
We found that economic activity and indigenous ethnicity were protective variables in larger cities when compared to smaller cities or rural areas, but this finding is unlikely to represent true protection; rather, it may suggest a lower proportional diagnosis in urban areas for indigenous population which may involve systemic underdiagnosis, cultural barriers, and underreporting in marginalized populations, consistent with prior work in Mexico and other Latin American countries [32,33]. Economically inactive individuals may have less access to medical insurance, which may explain the lower odds in larger cities compared to smaller ones. These disparities emphasize the need for culturally appropriate diagnostic approaches and improved access to specialized care in underserved regions.
At the state-cluster level, states with longer life expectancy reported higher dementia mortality, consistent with the demographic transition theory claiming that populations that survive longer inevitably face greater dementia burden [34,35]. However, states with a higher proportion of older adults did not necessarily show higher mortality. This counterintuitive result may reflect competing mortality risks in less developed regions, where older adults die earlier of other causes, reducing the probability of dementia being recorded as a basic cause of death [36].
Insurance coverage was not significantly associated with dementia mortality at the state level, despite being protective at the individual level. This discrepancy underscores the ecological fallacy, where population-level measures do not capture individual realities. It also suggests that affiliation alone may not guarantee timely diagnosis or adequate dementia care, as Mexico’s fragmented health system faces persistent inequities in service quality and access for the most vulnerable population [37,38,39].
The present study provides a comprehensive, annual national analysis of dementia-related mortality in Mexico, integrating both microdata and ecological indicators. It addresses prior gaps by disentangling individual and population-level associations and correcting for temporal trends. Our findings underscore the urgent need to strengthen dementia surveillance and care in Mexico. Improved diagnostic accuracy, particularly in underserved populations, is critical for reliable monitoring. Policies addressing the growing dementia burden must consider both demographic pressures (increasing life expectancy) and structural inequities (limited access in Indigenous and rural communities). Integrated approaches that combine public health, clinical care, and social support are necessary to ensure equitable management of dementia across Mexico.
The fact that health care affiliation does not correlate proportionally correlate to the population aging or the increase in life expectancy suggests, that if no systematic changes in health care coverage are implemented, with the continuous increase in life expectancy, population aging and dementia, Mexican adult population may face unmet needs for dementia related care, medical attention for the elderly in variable proportion, dependent on sociodemographic determinants at the individual and collective level. Policies for integrating health care resources and allocating them in equal manner to the aging population are needed, along with a collective sense of empathy and humanity to endorse and promote public policies for caring for the elderly.

Limitation

Dementia seemingly remains underdiagnosed and underreported on death certificates, especially in rural populations and for underserved human groups. We based our study on ICD-10 codes and therefore could not distinguish between dementia subtypes, limiting etiologic insights. Even when the mortality rate provides an epidemiological measure of dementia, it is unclear whether the prevalence and real burden of the disease in Mexico; future studies may address this gap. Finally, state-cluster analyses may be interpreted with caution, to avoid precluding direct inference from state-level patterns to individual risk.

5. Conclusions

Dementia-related mortality in Mexico rose continuously between 2017 and 2023 nationally, with an expected annual increase of 18.6% and upward trends were observed in every state. Previous studies did not provide individual-level data alongside state-cluster correlates. This increase reflects both demographic changes associated with population aging and improved recognition of dementia in clinical and vital statistics. At the individual level, disparities were evident, including paradoxical associations such as higher risk among more educated groups and lower risk among Indigenous populations, likely reflecting differences in diagnostic practices, reporting, and survival. At the state-cluster level, longer life expectancy was a robust predictor of dementia mortality. In contrast, population aging and insurance coverage did not correlate, underscoring the complexity of structural influences and the need for a robust, inclusive health system to support the aging population equally.
These findings underscore the importance of developing integrated and equitable strategies for dementia surveillance and care. Strengthening dementia surveillance, improving diagnostic accuracy in underserved populations, and addressing inequities in access to health care and social support are critical to prepare Mexico for the growing dementia burden. National strategies must integrate demographic realities with targeted interventions to ensure equitable recognition, treatment, and care for older adults living with dementia.

Author Contributions

Data curation, A.M.C.-S., P.A.B.-C. and R.J.-A.; Investigation, D.M.L.-S., A.M.C.-S., E.V.-J. and C.R.P.-M.; Methodology, R.J.-A. and N.M.-D.; Project administration, N.M.-D.; Resources, A.M.C.-S. and P.A.B.-C.; Software, P.A.B.-C. and R.J.-A.; Supervision, N.M.-D.; Validation, J.C.G.-H. and S.E.M.-M.; Visualization, J.C.G.-H.; Writing—original draft, D.M.L.-S., E.V.-J. and C.R.P.-M.; Writing—review and editing, S.E.M.-M. and N.M.-D. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by IMSS-BIENESTAR PP-E006.

Institutional Review Board Statement

This study was approved by the Research Board of HRAEPY under number 2024-033, date of approval: 27 July 2025.

Informed Consent Statement

Patient consent was waived. Records were obtained from the National Institute of Statistics and Geography (INEGI), Estadísticas de Defunciones Registradas (2017 and 2023). It is a public database providing critical data to support decision-making in government, business, academia, and civil society.

Data Availability Statement

The original data presented in the study are openly available at https://www.inegi.org.mx/programas/edr/#datos_abiertos (accessed on 12 July 2025).

Conflicts of Interest

The authors declare no conflicts of interest.

Abbreviations

The following abbreviations are used in this manuscript:
HALEHealth-adjusted life expectancy
YLDYears lived with disability
DALYDisability-adjusted life-years
CONAPONational Population Council
INEGINational Institute of Geography and Statistics
OROdds ratios
CIConfidence intervals

References

  1. Prince, M.; Wimo, A.; Guerchet, M.; Ali, G.C.; Wu, Y.-T.; Prina, M. The World Alzheimer Report 2015: The Global Impact of Dementia; Alzheimer’s Disease International: London, UK, 2015. [Google Scholar]
  2. Mackenbach, J.P.; Looman, C.W.N. Life expectancy and national income in Europe, 1900–2008: An update of Preston’s analysis. Int. J. Epidemiol. 2013, 42, 1100–1110. [Google Scholar] [CrossRef]
  3. Marmot, M. Social determinants of health inequalities. Lancet 2005, 365, 1099–1104. [Google Scholar] [CrossRef]
  4. Salomon, J.A.; Wang, H.; Freeman, M.K.; Vos, T.; Flaxman, A.D.; Lopez, A.D.; Murray, C.J.L. Healthy life expectancy for 187 countries, 1990–2010: A systematic analysis for the Global Burden Disease Study 2010. Lancet 2012, 380, 2144–2162. [Google Scholar] [CrossRef]
  5. Mathers, C.D.; Stevens, G.A.; Boerma, T.; White, R.A.; Tobias, M.I. Causes of international increases in older age life expectancy. Lancet 2015, 385, 540–548. [Google Scholar] [CrossRef]
  6. Jagger, C.; Weston, C.; Cambois, E.; Van Oyen, H.; Nusselder, W.; Doblhammer, G.; Rychtarikova, J.; Robine, J.M.; The EHLEIS Team. Inequalities in health expectancies at older ages in the European Union: Findings from the Survey of Health and Retirement in Europe (SHARE). J. Epidemiol. Community Health 2011, 65, 1030–1035. [Google Scholar] [CrossRef]
  7. Yong, V.; Saito, Y. Trends in healthy life expectancy in Japan: 1986–2004. Demogr. Res. 2009, 20, 467–494. [Google Scholar] [CrossRef]
  8. Cheng, X.; Jia, W.; Zhou, J.; Xu, Y.; Zou, J.; Liu, M.; Jiang, S.; Li, X. Changes and trends in mortality, disability-adjusted life years, life expectancy, and healthy life expectancy in China from 1990 to 2021: A secondary analysis of the Global Burden of Disease 2021. Arch. Public Health 2025, 83, 93. [Google Scholar] [CrossRef]
  9. Reyes-Beaman, S.; Jagger, C.; García-Peña, C.; Muñoz, O.; Beaman, P.E.; Stafford, B.; National Group of Research on Ageing. Active life expectancy of older people in Mexico. Disabil. Rehabil. 2005, 27, 213–219. [Google Scholar] [CrossRef] [PubMed]
  10. Payne, C.F.; Wong, R. Expansion of disability across successive Mexican birth cohorts: A longitudinal modeling analysis of birth cohorts born ten years apart. J. Epidemiol. Community Health 2019, 73, 900–905. [Google Scholar] [CrossRef] [PubMed]
  11. Wong, R.; Michaels-Obregón, A.; Palloni, A. Cohort profile: The Mexican Health and Aging Study (MHAS). Int. J. Epidemiol. 2017, 46, e2. [Google Scholar] [CrossRef] [PubMed]
  12. Doubova Dubova, S.V.; Pérez-Cuevas, R.; Espinosa-Alarcón, P.; Flores-Hernández, S. Social network types and functional dependency in older adults in Mexico. BMC Public Health 2010, 10, 104. [Google Scholar] [CrossRef]
  13. Angel, J.L.; Vega, W.; López-Ortega, M. Aging in Mexico: Population trends and emerging issues. Gerontologist 2017, 57, 153–162. [Google Scholar] [CrossRef] [PubMed]
  14. Armenta-Paulino, N.; Wehrmeister, F.C.; Arroyave, L.; Barros, A.J.D.; Victora, C.G. Ethnic inequalities in health intervention coverage among Mexican women at the individual and municipality levels. EClinicalMedicine 2021, 36, 101228. [Google Scholar] [CrossRef]
  15. Cortés-Adame, L.J.; Gómez-Dantés, O. The termination of Seguro Popular: Impacts on the care of high-cost diseases in the uninsured population in Mexico. Lancet Reg. Health Am. 2025, 46, 101078. [Google Scholar] [CrossRef]
  16. González-Nuñez, J.; Domínguez, S.; Zimmermann, K.J. Characterizing uninsured population in Mexico: A multinomial analysis. Rev. Behav. Financ. 2025, 17, 83–99. [Google Scholar] [CrossRef]
  17. Álvarez-Aceves, M.; Palacio-Mejía, L.S.; Hernández-Ávila, M.; González-González, E.L.; Castro-Del Ángel, C.A.; Guzmán-Sandoval, L.; Hernández-Ávila, J.E. 23 years of public policy towards universal health coverage in Mexico. A cross-sectional time-series analysis using routinely collected health data, 2000–2022. Lancet Reg. Health Am. 2025, 52, 101271. [Google Scholar] [CrossRef]
  18. Consejo Nacional de Población (CONAPO). Proyecciones de la Población de México y de las Entidades Federativas 2016–2050; CONAPO: Ciudad de México, México, 2018. [Google Scholar]
  19. Janssen-Aguilar, R.; Erosa-Villarreal, R.A.; González-Maldonado, L.A.; Méndez-Domínguez, N.I.; Inurreta-Díaz, M.J. Epidemiological characteristics of dementia-related mortality in Mexico between 2012 and 2016. Rev. Mex. Neurocienc. 2019, 20, 222–228. [Google Scholar] [CrossRef]
  20. Murata, S.; Takegami, M.; Onozuka, D.; Nakaoku, Y.; Hagihara, A.; Nishimura, K. Incidence and mortality of dementia-related missing and their associated factors: An ecological study in Japan. J. Epidemiol. 2021, 31, 361–368. [Google Scholar] [CrossRef] [PubMed]
  21. Li, Z.; Yang, N.; He, L.; Wang, J.; Yang, Y.; Ping, F.; Xu, L.; Zhang, H.; Li, W.; Li, Y. Global burden of dementia death from 1990 to 2019, with projections to 2050: An analysis of 2019 Global Burden of Disease Study. J. Prev. Alzheimers Dis. 2024, 11, 1013–1021. [Google Scholar] [CrossRef] [PubMed]
  22. Stephan, B.C.M.; Birdi, R.; Tang, E.Y.H.; Cosco, T.D.; Donini, L.M.; Licher, S.; Ikram, M.A.; Siervo, M.; Robinson, L. Secular trends in dementia prevalence and incidence worldwide: A systematic review. J. Alzheimers Dis. 2018, 66, 653–680. [Google Scholar] [CrossRef]
  23. Pirayesh, Z.; Riahi, S.M.; Bidokhti, A.; Kazemi, T. Evaluation of the effect of the COVID-19 pandemic on all-cause and cause-specific mortality, YLL, and life expectancy in the first two years in an Iranian population: An ecological study. Front. Public Health 2023, 11, 1259202. [Google Scholar] [CrossRef]
  24. Ghosh, K.; Stewart, S.T.; Raghunathan, T.; Cutler, D.M. Medical visits and mortality among dementia patients during the COVID-19 pandemic compared to rates predicted from 2019. BMC Geriatr. 2024, 24, 727. [Google Scholar] [CrossRef]
  25. Chen, R.; Charpignon, M.L.; Raquib, R.V.; Wang, J.; Meza, E.; Aschmann, H.E.; DeVost, M.A.; Mooney, A.; Bibbins-Domingo, K.; Riley, A.R.; et al. Excess mortality with Alzheimer disease and related dementias during the COVID-19 pandemic in the United States. JAMA Neurol. 2023, 80, 919–928. [Google Scholar] [CrossRef]
  26. Barría-Sandoval, C.; Ferreira, G.; Navarrete, J.P.; Farhang, M. The impact of COVID-19 on deaths from dementia and Alzheimer’s disease in Chile: An analysis of panel data for 16 regions, 2017–2022. Lancet Reg. Health Am. 2024, 2, 100726. [Google Scholar] [CrossRef]
  27. Romero, J.P.; Benito-León, J.; Mitchell, A.J.; Trincado, R.; Bermejo-Pareja, F. Underreporting of dementia deaths on death certificates using data from a population-based study (NEDICES). J. Alzheimers Dis. 2014, 39, 741–748. [Google Scholar] [CrossRef] [PubMed]
  28. Morros-Serra, M.; Melendo-Azuela, E.M.; Garre-Olmo, J.; Turró-Garriga, O.; Santaeugènia, S. Sex differences in dementia diagnosis: A fourteen-year retrospective analysis using the Registry of Dementia of Girona. J. Women Aging 2025, 37, 72–85. [Google Scholar] [CrossRef]
  29. World Health Organization. Global Status Report on the Public Health Response to Dementia; WHO: Geneva, Switzerland, 2021. [Google Scholar]
  30. Wimo, A.; Guerchet, M.; Ali, G.C.; Wu, Y.-T.; Prina, A.M.; Winblad, B.; Jönsson, L.; Liu, Z.; Prince, M. The worldwide costs of dementia 2015 and comparisons with 2010. Alzheimers Dement. 2017, 13, 1–7. [Google Scholar] [CrossRef] [PubMed]
  31. Spijker, J.J.; Calazans, J.A.; Trias-Llimós, S.; Renteria, E.; Doblhammer, G. Educational inequalities in dementia-related mortality and their contribution to life expectancy differences in Spain. Sci. Rep. 2025, 15, 26838. [Google Scholar] [CrossRef] [PubMed]
  32. Giebel, C.; Readman, M.R.; Godfrey, A.; Gray, A.; Carton, J.; Polden, M. Geographical inequalities in dementia diagnosis and care: A systematic review. Int. Psychogeriatr. 2025, 37, 100051. [Google Scholar] [CrossRef]
  33. de Souza-Talarico, J.N.; de Carvalho, A.P.; Brucki, S.M.; Nitrini, R.; Ferretti-Rebustini, R.E. Dementia and cognitive impairment prevalence and associated factors in Indigenous populations: A systematic review. Alzheimer Dis. Assoc. Disord. 2016, 30, 281–287. [Google Scholar] [CrossRef]
  34. Yoshikawa, M.; Goto, E.; Shin, J.H.; Imanaka, Y. Regional disparities in dementia-free life expectancy in Japan: An ecological study using the long-term care insurance claims database. PLoS ONE 2023, 18, e0280299. [Google Scholar] [CrossRef] [PubMed]
  35. Wolters, F.J.; Tinga, L.M.; Dhana, K.; Koudstaal, P.J.; Hofman, A.; Bos, D.; Franco, O.H.; Ikram, M.A. Life expectancy with and without dementia: A population-based study of dementia burden and preventive potential. Am. J. Epidemiol. 2019, 188, 372–381. [Google Scholar] [CrossRef] [PubMed]
  36. Murray, C.J.L.; Lopez, A.D. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 1997, 349, 1436–1442. [Google Scholar] [CrossRef] [PubMed]
  37. González Block, M.A.; Reyes Morales, H.; Cahuana Hurtado, L.; Balandrán, A.; Hernández, E.M.; Allin, S. Health Systems in Transition: Mexico; University of Toronto Press: Toronto, ON, Canada, 2021. [Google Scholar]
  38. Alcalde-Rabanal, J.E.; Molina-Rodríguez, J.F.; Díaz-Portillo, S.P.; Hoyos-Loya, E.; Reyes-Morales, H. El sistema de salud de México: Análisis de sus logros y desafíos en el periodo 2015–2022. Salud Publica Mex. 2024, 66, 677–688. [Google Scholar] [CrossRef]
  39. Waller, M.; Buckley, R.F.; Masters, C.L.; Nona, F.R.; Eades, S.J.; Dobson, A.J. Deaths with dementia in Indigenous and non-Indigenous Australians: A nationwide study. J. Alzheimers Dis. 2021, 81, 1589–1599. [Google Scholar] [CrossRef]
Epidemiologia 07 00014 g001
Figure 1. Observed rates were calculated using annual death counts attributed to dementia and mid-year population estimates for adults aged ≥65 years obtained from CONAPO. Expected rates were derived from a log-linear Poisson regression model fitted to 2017 to 2019 data, assuming exponential growth (annual expected increase = 18.6%). A transient decline was noted in 2020 to 2022, coinciding with the COVID-19 pandemic, followed by partial recovery in 2023.
Figure 1. Observed rates were calculated using annual death counts attributed to dementia and mid-year population estimates for adults aged ≥65 years obtained from CONAPO. Expected rates were derived from a log-linear Poisson regression model fitted to 2017 to 2019 data, assuming exponential growth (annual expected increase = 18.6%). A transient decline was noted in 2020 to 2022, coinciding with the COVID-19 pandemic, followed by partial recovery in 2023.
Epidemiologia 07 00014 g001
Epidemiologia 07 00014 g002
Figure 2. The state-by-state comparative chart shows dementia mortality rates in the 2017 to 2023 period for all 32 states.
Figure 2. The state-by-state comparative chart shows dementia mortality rates in the 2017 to 2023 period for all 32 states.
Epidemiologia 07 00014 g002
Table 1. Sociodemographic characteristics of dementia-related deaths in Mexico, 2017 to 2023, in the population aged ≥65 years.
Table 1. Sociodemographic characteristics of dementia-related deaths in Mexico, 2017 to 2023, in the population aged ≥65 years.
Year Studied2017201820192020202120222023
Frequency761103511841052121113831425
Age (Mean, SD)85.4 (7.8)85.6 (7.7)85.3 (7.6)85.7 (7.5)84.8 (7.5)85.4 (7.8)85.7 (7.6)
Male (%)317 (41.8)411 (39.9)467 (39.8)425 (40.4)458 (37.7)506 (36.9)567 (40.0)
Indigenous ethnicity (%)51 (6.7)77 (7.3)76 (6.4)58 (5.5)141 (13.3)81 (5.8)81 (5.7)
≥Elementary education (%)100 (13.1)149 (14.4)171 (14.4)176 (16.7)192 (15.8)240 (17.3)279 (19.4)
Economically active (%)192 (25.2)349 (33.4)264 (22.2)237 (22.5)270 (22.1)284 (20.5)307 (21.5)
Residence < 500 k people (%)463 (60.7)608(58.4)687 (57.7)651 (61.8)714 (58.9)814 (58.6)797 (55.6)
Cohabiting with spouse (%)222 (29)309 (29.8)351 (29.6)300 (28.5)343 (28.4)364 (26.3)387 (26.9)
Medical insurance (%)646 (85.0)883 (85.5)992 (83.8)798 (75.9)847 (70.0)933 (67.8)977 (68.8)
Demographic and social attributes of decedents with dementia recorded nationwide from 2017 to 2023. Values represent counts with percentages in parentheses unless otherwise specified. Age is presented as mean ± standard deviation. Data indicate a gradual increase in total deaths, a predominance of female decedents, and a rise in educational attainment over time.
Table 2. Logistic regression of sociodemographic factors associated with town size of residence among dementia-related deaths in Mexico.
Table 2. Logistic regression of sociodemographic factors associated with town size of residence among dementia-related deaths in Mexico.
Sociodemographic CharacteristicOdds Ratiozp-Value95%
Confidence Interval
LowerUpper
Age (numeric, per year)1.000.080.9340.991.00
65–79 years0.89−2.070.0380.800.99
80–99 years1.112.070.0391.001.32
≥100 years0.97−0.180.8590.711.32
Gender (Male)0.78−5.33<0.0010.710.85
Economically active0.62−8.41<0.0010.560.70
High school or higher1.9110.69<0.0011.702.16
Cohabiting with a spouse0.99-0.100.9190.901.09
Medical insurance covers2.2214.130.0011.982.48
Indigenous ethnicity0.17−13.29<0.0010.130.22
Logistic regression of sociodemographic factors associated with the place of death in smaller cities (<500,000 inhabitants) among dementia-related deaths in Mexico, 2017–2023 (population aged ≥65 years).
Table 3. Non-parametric Poisson regression reporting coefficients between state-cluster dementia related mortality rate and statewide indicators for the 2017–2023 period and population aged ≥65 years.
Table 3. Non-parametric Poisson regression reporting coefficients between state-cluster dementia related mortality rate and statewide indicators for the 2017–2023 period and population aged ≥65 years.
State/Cluster CharacteristicCoefficientp-Value95% Confidence Intervals
LowerUpper
Life expectancy at birth2.490.0030.944.05
Population aging−0.210.016−0.38−0.04
Medical Insurance Coverage0.020.877−0.290.34
Pseudo R2 = 0.42Post hoc = 0.95
Non-parametric Poisson regression coefficients for the association between state-level dementia-related mortality rates and statewide demographic and health indicators in Mexico, 2017–2023, for the population aged ≥65 years.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Lopez-Samayoa, D.M.; Campos-Sosa, A.M.; Bojorquez-Chan, P.A.; Martinez-Medel, S.E.; Guillermo-Herrera, J.C.; Villarreal-Jimenez, E.; Janssen-Aguilar, R.; Peres-Mitre, C.R.; Mendez-Dominguez, N. Trends and Determinants of Dementia-Related Mortality in Mexico, 2017–2023. Epidemiologia 2026, 7, 14. https://doi.org/10.3390/epidemiologia7010014

AMA Style

Lopez-Samayoa DM, Campos-Sosa AM, Bojorquez-Chan PA, Martinez-Medel SE, Guillermo-Herrera JC, Villarreal-Jimenez E, Janssen-Aguilar R, Peres-Mitre CR, Mendez-Dominguez N. Trends and Determinants of Dementia-Related Mortality in Mexico, 2017–2023. Epidemiologia. 2026; 7(1):14. https://doi.org/10.3390/epidemiologia7010014

Chicago/Turabian Style

Lopez-Samayoa, Dennis M., Angel M. Campos-Sosa, Paola Asuncion Bojorquez-Chan, Sara E. Martinez-Medel, Jorge C. Guillermo-Herrera, Edgar Villarreal-Jimenez, Reinhard Janssen-Aguilar, Cristina Rodriguez Peres-Mitre, and Nina Mendez-Dominguez. 2026. "Trends and Determinants of Dementia-Related Mortality in Mexico, 2017–2023" Epidemiologia 7, no. 1: 14. https://doi.org/10.3390/epidemiologia7010014

APA Style

Lopez-Samayoa, D. M., Campos-Sosa, A. M., Bojorquez-Chan, P. A., Martinez-Medel, S. E., Guillermo-Herrera, J. C., Villarreal-Jimenez, E., Janssen-Aguilar, R., Peres-Mitre, C. R., & Mendez-Dominguez, N. (2026). Trends and Determinants of Dementia-Related Mortality in Mexico, 2017–2023. Epidemiologia, 7(1), 14. https://doi.org/10.3390/epidemiologia7010014

Article Metrics

Back to TopTop